Publication:
Nanopore Sequencing Enables Comprehensive Transposable Element Epigenomic Profiling.

dc.contributor.authorEwing, Adam D
dc.contributor.authorSmits, Nathan
dc.contributor.authorSanchez-Luque, Francisco J
dc.contributor.authorFaivre, Jamila
dc.contributor.authorBrennan, Paul M
dc.contributor.authorRichardson, Sandra R
dc.contributor.authorCheetham, Seth W
dc.contributor.authorFaulkner, Geoffrey J
dc.date.accessioned2023-02-09T09:47:56Z
dc.date.available2023-02-09T09:47:56Z
dc.date.issued2020-11-12
dc.description.abstractTransposable elements (TEs) drive genome evolution and are a notable source of pathogenesis, including cancer. While CpG methylation regulates TE activity, the locus-specific methylation landscape of mobile human TEs has to date proven largely inaccessible. Here, we apply new computational tools and long-read nanopore sequencing to directly infer CpG methylation of novel and extant TE insertions in hippocampus, heart, and liver, as well as paired tumor and non-tumor liver. As opposed to an indiscriminate stochastic process, we find pronounced demethylation of young long interspersed element 1 (LINE-1) retrotransposons in cancer, often distinct to the adjacent genome and other TEs. SINE-VNTR-Alu (SVA) retrotransposons, including their internal tandem repeat-associated CpG island, are near-universally methylated. We encounter allele-specific TE methylation and demethylation of aberrantly expressed young LINE-1s in normal tissues. Finally, we recover the complete sequences of tumor-specific LINE-1 insertions and their retrotransposition hallmarks, demonstrating how long-read sequencing can simultaneously survey the epigenome and detect somatic TE mobilization.
dc.identifier.doi10.1016/j.molcel.2020.10.024
dc.identifier.essn1097-4164
dc.identifier.pmid33186547
dc.identifier.unpaywallURLhttp://www.cell.com/article/S1097276520307310/pdf
dc.identifier.urihttp://hdl.handle.net/10668/16598
dc.issue.number5
dc.journal.titleMolecular cell
dc.journal.titleabbreviationMol Cell
dc.language.isoen
dc.organizationCentro Pfizer-Universidad de Granada-Junta de Andalucía de Genómica e Investigación Oncológica-GENYO
dc.page.number915-928.e5
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rights.accessRightsopen access
dc.subjectAlu
dc.subjectLINE-1
dc.subjectSVA
dc.subjectmethylation
dc.subjectnanopore
dc.subjectretrotransposon
dc.subject.meshDNA Methylation
dc.subject.meshDNA Transposable Elements
dc.subject.meshDNA, Neoplasm
dc.subject.meshEpigenesis, Genetic
dc.subject.meshEpigenome
dc.subject.meshFemale
dc.subject.meshGene Expression Profiling
dc.subject.meshGene Expression Regulation, Neoplastic
dc.subject.meshHumans
dc.subject.meshLong Interspersed Nucleotide Elements
dc.subject.meshMiddle Aged
dc.subject.meshNanopore Sequencing
dc.subject.meshNeoplasms
dc.subject.meshOrgan Specificity
dc.titleNanopore Sequencing Enables Comprehensive Transposable Element Epigenomic Profiling.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number80
dspace.entity.typePublication

Files